Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP945581.RACNSh5Fcc_yxcHMamHvNb3Y73d6S661fzDxlq_nGaDhA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP945581.RACNSh5Fcc_yxcHMamHvNb3Y73d6S661fzDxlq_nGaDhA130_assertion type Assertion NP945581.RACNSh5Fcc_yxcHMamHvNb3Y73d6S661fzDxlq_nGaDhA130_head.
- NP945581.RACNSh5Fcc_yxcHMamHvNb3Y73d6S661fzDxlq_nGaDhA130_assertion description "[Endocrine therapies that inhibit estrogen receptor (ER)-? signaling are the most common and effective treatment for ER-?-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945581.RACNSh5Fcc_yxcHMamHvNb3Y73d6S661fzDxlq_nGaDhA130_provenance.
- NP945581.RACNSh5Fcc_yxcHMamHvNb3Y73d6S661fzDxlq_nGaDhA130_assertion evidence source_evidence_literature NP945581.RACNSh5Fcc_yxcHMamHvNb3Y73d6S661fzDxlq_nGaDhA130_provenance.
- NP945581.RACNSh5Fcc_yxcHMamHvNb3Y73d6S661fzDxlq_nGaDhA130_assertion SIO_000772 22158035 NP945581.RACNSh5Fcc_yxcHMamHvNb3Y73d6S661fzDxlq_nGaDhA130_provenance.
- NP945581.RACNSh5Fcc_yxcHMamHvNb3Y73d6S661fzDxlq_nGaDhA130_assertion wasDerivedFrom befree-2016 NP945581.RACNSh5Fcc_yxcHMamHvNb3Y73d6S661fzDxlq_nGaDhA130_provenance.
- NP945581.RACNSh5Fcc_yxcHMamHvNb3Y73d6S661fzDxlq_nGaDhA130_assertion wasGeneratedBy ECO_0000203 NP945581.RACNSh5Fcc_yxcHMamHvNb3Y73d6S661fzDxlq_nGaDhA130_provenance.